Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Schroeder

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Cancer Research|November 26, 2013
Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cellsJae Won Choi, Mark A Schroeder, Jann N Sarkaria, et al.
Current Protocols in Pharmacology|July 12, 2011
Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discoveryBrett L Carlson, Jenny L Pokorny, Mark A Schroeder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2017
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic SyndromeMichael Slade, John F DiPersio, Peter Westervelt, et al.
Advanced Healthcare Materials|August 3, 2017
Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of GlioblastomaSara Pedron, Jacob S Hanselman, Mark A Schroeder, et al.
Bone Marrow Transplantation|April 19, 2022
Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access programMark A Schroeder, Parameswaran N Hari, Amy Blithe, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2023
The Dynamics of Financial Toxicity in Multiple MyelomaMark A Fiala, Alice E Silberstein, Mark A Schroeder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2017
Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In VivoMatthew L Cooper, Jaebok Choi, Darja Karpova, et al.
Leukemia Research|February 21, 2023
Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass studyMichael Slade, Mark Fiala, Sarah Kelley, et al.
Therapeutic Advances in Hematology|June 16, 2020
Insights into the role of the JAK/STAT signaling pathway in graft-<i>versus</i>-host diseaseRamzi Abboud, Jaebok Choi, Peter Ruminski, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2019
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible MechanismsScott R Goldsmith, Mark A Fiala, Julie O'Neal, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Cancer Research|November 26, 2013
Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cellsJae Won Choi, Mark A Schroeder, Jann N Sarkaria, et al.
Current Protocols in Pharmacology|July 12, 2011
Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discoveryBrett L Carlson, Jenny L Pokorny, Mark A Schroeder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2017
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic SyndromeMichael Slade, John F DiPersio, Peter Westervelt, et al.
Advanced Healthcare Materials|August 3, 2017
Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of GlioblastomaSara Pedron, Jacob S Hanselman, Mark A Schroeder, et al.
Bone Marrow Transplantation|April 19, 2022
Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access programMark A Schroeder, Parameswaran N Hari, Amy Blithe, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2023
The Dynamics of Financial Toxicity in Multiple MyelomaMark A Fiala, Alice E Silberstein, Mark A Schroeder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2017
Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In VivoMatthew L Cooper, Jaebok Choi, Darja Karpova, et al.
Leukemia Research|February 21, 2023
Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass studyMichael Slade, Mark Fiala, Sarah Kelley, et al.
Therapeutic Advances in Hematology|June 16, 2020
Insights into the role of the JAK/STAT signaling pathway in graft-<i>versus</i>-host diseaseRamzi Abboud, Jaebok Choi, Peter Ruminski, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2019
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible MechanismsScott R Goldsmith, Mark A Fiala, Julie O'Neal, et al.
Pageof 11